| DNA damage enhancement from gold nanoparticles for clinical MV photon beams. | |
| | |
MedLine Citation:
|
PMID: 23148509 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
In this study, we quantify the relative damage enhancement due to the presence of gold nanoparticles (GNP) in vitro in a clinical 6 MV beam for various delivery parameters and depths. It is expected that depths and delivery modes that produce a larger proportions of low-energy photons will have a larger effect on the cell samples containing GNP. HeLa cells with and without 50 nm GNP were irradiated at depths of 1.5, 5, 10, 15 and 20 cm. Conventional beams with square aperture sizes 5, 10 and 15 cm at isocenter, and flattening filter free (FFF) beams were used. Relative DNA damage enhancement with GNP was evaluated by γ-H2AX staining. Statistically significant increases in DNA damage with GNP, compared to the absence of GNP, were observed for all depths and delivery modes. Relative to the shallowest depth, damage enhancement was observed to increase as a function of increasing depth for all deliveries. For the conventional (open field) delivery, DNA damage enhancement with GNP was seen to increase as a function of field size. For FFF delivery, a substantial increase in enhancement was found relative to the conventional field delivery. The measured relative DNA damage enhancement validates the theoretically predicted trends as a function of depth and delivery mode for clinical MV photon beams. The results of this study open new possibilities for the clinical development of gold nanoparticle-aided radiation therapy. |
| | |
Authors:
|
Ross I Berbeco; Houari Korideck; Wilfred Ngwa; Rajiv Kumar; Janki Patel; Srinivas Sridhar; Sarah Johnson; Brendan D Price; Alec Kimmelman; G Mike Makrigiorgos |
Related Documents
:
|
1949039 - Dna cross-linking in mammalian cells by pyrrolizidine alkaloids: structure-activity rel... 2101869 - Fanconi's anemia: genetic and molecular aspects of the defect. 9736489 - Sequence-specific photomodification of dna by an oligonucleotide-phenanthrodihydrodioxi... 21564929 - Coi barcodes for identification of merodon hoverflies (diptera, syrphidae) of lesvos is... 1761569 - Interaction of the uvrabc endonuclease with dna containing a psoralen monoadduct or cro... 23107739 - Assessment of the ability of seaweed extracts to protect against hydrogen peroxide and ... 3383359 - Expression of ventricular-type myosin light chain messenger rna in spontaneously hypert... 14563529 - Dna strand breaks induced by the anti-topoisomerase ii bis-dioxopiperazine icrf-193. 20569209 - Enzymatic approaches and bisulfite sequencing cannot distinguish between 5-methylcytosi... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't Date: 2012-11-13 |
Journal Detail:
|
Title: Radiation research Volume: 178 ISSN: 1938-5404 ISO Abbreviation: Radiat. Res. Publication Date: 2012 Dec |
Date Detail:
|
Created Date: 2012-12-12 Completed Date: 2013-02-06 Revised Date: 2013-04-16 |
Medline Journal Info:
|
Nlm Unique ID: 0401245 Medline TA: Radiat Res Country: United States |
Other Details:
|
Languages: eng Pagination: 604-8 Citation Subset: IM; S |
Affiliation:
|
Department of Radiation Oncology, Division of Medical Physics and Biophysics, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA. rberbeco@lroc.harvard.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
DNA Damage* Gold / chemistry*, pharmacology* HeLa Cells Humans Metal Nanoparticles* Photons / therapeutic use* |
| Grant Support | |
ID/Acronym/Agency:
|
CA93602/CA/NCI NIH HHS; R01 CA093602/CA/NCI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
7440-57-5/Gold |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Variations in the RBE for Cell Killing Along the Depth-Dose Profile of a Modulated Proton Therapy Be...
Next Document: Proline Catalyzed ?-Aminoxylation Reaction in the Synthesis of Biologically Active Compounds.